Parkinson
Randomized trial of preladenant, given as monotherapy, in patients with early Parkinson disease
Neurology Journal Published online: May 10, 2017 DOI: http://dx.doi.org/10.1212/WNL.0000000000004003 Fabrizio Stocchi, MD, PhD, Olivier Rascol, MD, Robert A. Hauser, MD,...
REM sleep behaviour disorder: prodromal and mechanistic insights for Parkinson’s disease
Journal of Neurology, Neurosurgery & Psychiatry Volume 88, Issue 5, Published online 4 May 2017 Anand Tekriwal, Drew S Kern, Jean...
ICARUS study: prevalence and clinical features of impulse control disorders in Parkinson’s disease
Journal of Neurology, Neurosurgery & Psychiatry Volume 88, Issue 4 Angelo Antonini, Paolo Barone, Ubaldo Bonuccelli, Karin Annoni, Mahnaz Asgharnejad, Paolo...
Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies
The Lancet Neurology Volume 16, No. 5, p351–359, May 2017 Dr Daryl J Wile, Pankaj A Agarwal, DM, Prof Michael...
Decrease in Aβ42 predicts dopa-resistant gait progression in early Parkinson disease
Neurology Journal April 18, 2017 vol. 88 no. 16 1501-1511 Lynn Rochester, PhD, Brook Galna, PhD, Sue Lord, PhD, Alison J. Yarnall, MRCP, Rosie Morris, MSc, Gordon Duncan,...
Lo más popular
«Con los ojos de un niño» Cómic de Unidos Contra el Parkinson para explicar la enfermedad... 
Nuevas vías de investigación contra el Parkinson 
Changes in insomnia subtypes in early Parkinson disease 
Corpus callosal atrophy and associations with cognitive impairment in Parkinson disease 
Awake versus asleep deep brain stimulation for Parkinson’s disease: a critical compa... 
REM sleep behaviour disorder: prodromal and mechanistic insights for Parkinson’s dis... 
Los farmacéuticos informan sobre la vacunación contra el covid-19 a pacientes de párkinson